Atlas Trials

Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis

Clinical trial NCT02037347 · TERMINATED

Trial details

NCT number
NCT02037347
Sponsor
Brett King
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Toxic Epidermal NecrolysisStevens-Johnson Syndrome
Start date
2010-10-01
Primary completion
2014-12-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.